Inozyme Pharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Inozyme Pharma and other ETFs, options, and stocks.

About INZY

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton.

CEO

Douglas A. Treco

CEODouglas A. Treco

Employees

Employees59

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2015

Founded2015

Employees

Employees59

INZY Key Statistics

Market cap

271.80M

Market cap271.80M

Price-Earnings ratio

-3.17

Price-Earnings ratio-3.17

Dividend yield

—

Dividend yield—

Average volume

658.74K

Average volume658.74K

High today

$4.49

High today$4.49

Low today

$4.35

Low today$4.35

Open price

$4.40

Open price$4.40

Volume

475.26K

Volume475.26K

52 Week high

$7.80

52 Week high$7.80

52 Week low

$2.69

52 Week low$2.69

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

Inozyme Pharma

Why Robinhood?

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. Show more

INZY Key Statistics

Analyst ratings

100%

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton.